Discovery of Apararenone (MT-3995) as a Highly Selective, Potent, and Novel Nonsteroidal Mineralocorticoid Receptor Antagonist | Journal of Medicinal Chemistry
IJMS | Free Full-Text | Endothelial Dysfunction in Primary Aldosteronism
Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review | Journal of the American College of Cardiology
Сватбени аксесоари Надя
Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease - Zhang - 2022 - Advanced Materials - Wiley Online Library
IJMS | Free Full-Text | Vitamin D as A Protector of Arterial Health: Potential Role in Peripheral Arterial Disease Formation
Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists | Journal of Medicinal Chemistry
JCM | Free Full-Text | Current and Emerging Medical Therapies in Pituitary Tumors
Krasi Elenkova (kokolino_75) - Profile | Pinterest
Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists | Journal of Medicinal Chemistry
Frontiers | Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study
Molecules | December-1 2021 - Browse Articles
Probing a Complex of Cytochrome c and Cardiolipin by Magnetic Circular Dichroism Spectroscopy: Implications for the Initial Events in Apoptosis | Journal of the American Chemical Society
The impact of thyroid hormone dysfunction on ischemic heart disease in: Endocrine Connections Volume 8 Issue 5 (2019)
Pyclen-Based Ln(III) Complexes as Highly Luminescent Bioprobes for In Vitro and In Vivo One- and Two-Photon Bioimaging Applications | Journal of the American Chemical Society